Abstract
AimsMitogen-activated protein kinase (MAPK) pathway alteration is a major oncogenic driver in paediatric low-grade gliomas (LGG) and some adult gliomas, encompassing BRAF (most common) and non-BRAF alterations. The aim was...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have